UK Government advisers recommend extending funding for human papillomavirus (HPV) vaccines to boys.
Since 2008, girls aged between 12-13 years old in the UK have been receiving HPV jags to prevent against cervical cancer. Most cases of cervical cancer are caused by certain strains of HPV, which can be transmitted through sexual contact. Cervical cancer can be very serious. After breast cancer, cervical cancer is the most common women’s cancer in the world and HPV is the main risk factor. Each year in Britain, it claims the lives of around 1,000 women. The HPV vaccine will be offered to boys.
hpv vaccine offered to boys.
Government advisors have made a new recommendation to extend the vaccination to boys, meaning that 400,000 boys will also benefit from the vaccine every year. This decision follows demands for the scheme to be made available to both males and females to protect more youngsters from some forms of cancer.
Pressure came from those in the dental profession. Numerous bodies in the dental industry have been campaigning for the vaccination to be extended to boys for a while, as dentists are often the first to spot the signs of the HPV virus. They believe that everyone should be able to benefit from the vaccination. Statistics show that oral cancer claims more lives than road accidents, and that men are twice as likely as women to develop it. If that’s not a good enough reason for boys to receive the vaccine, we don’t know what is.
When will treatment begin?
Well, further delays will only cost lives. As far as we know, this campaign is set to role out by September 2019 to implement these vaccinations. As of yet, we don’t know what ages the vaccines will be administered. We believe it will be somewhat close to the 12-13 age bracket that the girls received their treatment. We will announce more information when we find out!
What do you think?
What do you think about the vaccine being extended to boys? Do you think it’s a good idea? Do you think it should have been offered to them sooner? Let us know in the comments.